Polysaccharide-based nanoparticles for theranostic nanomedicine

Advanced Drug Delivery Reviews

Volumn 99, Issue , 2016, Pages 70-84

  Swierczewska, M ^a   Han, H S ^b   Kim, K ^c   Park, J H ^b   Lee, S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Sungkyunkwan University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Carbohydrate; Chitosan; Drug delivery; Hyaluronan; Molecular imaging; Nanoparticles

Indexed keywords

CARBOHYDRATES; CHITIN; CHITOSAN; CROSSLINKING; DRUG DELIVERY; HYALURONIC ACID; MEDICAL NANOTECHNOLOGY; MOLECULAR IMAGING; MOLECULES; PHOTOSENSITIZERS; POLYSACCHARIDES; PROTEINS;

BIOLOGICAL MOLECULE; DIAGNOSTIC AGENTS; FUNCTIONALIZATIONS; HYALURONAN; INTEGRATED APPROACH; NANOPARTICLE FORMATION; SMALL MOLECULES; THERANOSTIC NANOMEDICINE;

NANOPARTICLES;

CARBOHYDRATE; CHITOSAN; CHITOSAN DERIVATIVE; CISPLATIN; CYCLODEXTRIN; DEXTRAN; DIAGNOSTIC AGENT; DIATRIZOATE; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; GADOLINIUM PENTETATE MEGLUMINE; GOLD NANOPARTICLE; HEPARIN; HYALURONIC ACID; LYSOZYME; NANOPARTICLE; PEPTIDE; PHOTOSENSITIZING AGENT; POLY(PYRIDYL DISULFIDE METHACRYLATE); POLYELECTROLYTE; POLYESTER; POLYMER; POLYSACCHARIDE; PULLULAN; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TALAPORFIN; THIOCTIC ACID; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIODEGRADABILITY; CROSS LINKING; DRUG DELIVERY SYSTEM; HUMAN; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SURFACE CHARGE; THERANOSTIC NANOMEDICINE; ANIMAL; CHEMISTRY;

ANIMALS; HUMANS; NANOPARTICLES; POLYSACCHARIDES; THERANOSTIC NANOMEDICINE;

EID: 84960306658     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.11.015     Document Type: Review

References (158)

1. Adachi N., Maruyama A., Ishihara T., Akaike T. Cellular distribution of polymer particles bearing various densities of carbohydrate ligands. J. Biomater. Sci. Polym. Ed. 1994, 6:463-479.
2. Maruyama A., Ishihara T., Adachi N., Akaike T. Preparation of nanoparticles bearing high density carbohydrate chains using carbohydrate-carrying polymers as emulsifier. Biomaterials 1994, 15:1035-1042.
3. Xie J., Lee S., Chen X. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 2010, 62:1064-1079.
4. Toy R., Bauer L., Hoimes C., Ghaghada K.B., Karathanasis E. Targeted nanotechnology for cancer imaging. Adv. Drug Deliv. Rev. 2014, 76:79-97.
5. Weissleder R., Kelly K., Sun E.Y., Shtatland T., Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol. 2005, 23:1418-1423.
6. Mammen M., Choi S.-K., Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 1998, 37:2754-2794.
7. Jiang W., KimBetty Y.S., Rutka J.T., ChanWarren C.W. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3:145-150.
8. Lee S.Y., Jeon S.I., Jung S., Chung I.J., Ahn C.-H. Targeted multimodal imaging modalities. Adv. Drug Deliv. Rev. 2014, 76:60-78.
9. Jokerst J.V., Gambhir S.S. Molecular imaging with theranostic nanoparticles. Acc. Chem. Res. 2011, 44:1050-1060.
10. Chauhan V.P., Stylianopoulos T., Boucher Y., Jain R.K. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu. Rev. Chem. Biomol. Eng. 2011, 2:281-298.
11. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653-664.
12. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284.
13. Maeda H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv. Drug Deliv. Rev. 2015, 91:3-6.
14. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
15. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004, 56:1649-1659.
16. Janib S.M., Moses A.S., MacKay J.A. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Deliv. Rev. 2010, 62:1052-1063.
17. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7:771-782.
18. Bertrand N., Wu J., Xu X.Y., Kamaly N., Farokhzad O.C. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014, 66:2-25.
19. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 2008, 60:1650-1662.
20. Bhattarai N., Gunn J., Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev. 2010, 62:83-99.
21. Park J.H., Saravanakumar G., Kim K., Kwon I.C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 2010, 62:28-41.
22. Mizrahy S., Peer D. Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 2012, 41:2623-2640.
23. Yang X., Du H., Liu J., Zhai G. Advanced nanocarriers based on heparin and its derivatives for cancer management. Biomacromolecules 2015, 16:423-436.
24. Ganguly K., Chaturvedi K., More U.A., Nadagouda M.N., Aminabhavi T.M. Polysaccharide-based micro/nanohydrogels for delivering macromolecular therapeutics. J. Control. Release 2014, 193:162-173.
25. Saravanakumar G., Jo D.G., Park J.H. Polysaccharide-based nanoparticles: a versatile platform for drug delivery and biomedical imaging. Curr. Med. Chem. 2012, 19:3212-3229.
26. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60:1627-1637.
27. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 2003, 7:626-634.
28. Kim H., Kim Y., Kim I.-H., Kim K., Choi Y. ROS-responsive activatable photosensitizing agent for imaging and photodynamic therapy of activated macrophages. Theranostics 2014, 4:1-11.
29. Li L., Nurunnabi M., Nafiujjaman M., Lee Y.-k., Huh K.M. GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy. J. Control. Release 2013, 171:241-250.
30. Liu P., Yue C., Sheng Z., Gao G., Li M., Yi H., Zheng C., Wang B., Cai L. Photosensitizer-conjugated redox-responsive dextran theranostic nanoparticles for near-infrared cancer imaging and photodynamic therapy. Polym. Chem. 2014, 5:874-881.
31. Yoon H.Y., Koo H., Choi K.Y., Lee S.J., Kim K., Kwon I.C., Leary J.F., Park K., Yuk S.H., Park J.H., Choi K. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33:3980-3989.
32. Cai H., Yao P. In situ preparation of gold nanoparticle-loaded lysozyme-dextran nanogels and applications for cell imaging and drug delivery. Nanoscale 2013, 5:2892-2900.
33. Caldorera-Moore M.E., Liechty W.B., Peppas N.A. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. Acc. Chem. Res. 2011, 44:1061-1070.
34. Hrkach J., Von Hoff D., Ali M.M., Andrianova E., Auer J., Campbell T., De Witt D., Figa M., Figueiredo M., Horhota A., Low S., McDonnell K., Peeke E., Retnarajan B., Sabnis A., Schnipper E., Song J.J., Song Y.H., Summa J., Tompsett D., Troiano G., Van Geen Hoven T., Wright J., LoRusso P., Kantoff P.W., Bander N.H., Sweeney C., Farokhzad O.C., Langer R., Zale S. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci. Transl. Med. 2012, 4. (128ra139).
35. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B. 2010, 75:1-18.
36. Ghosh S.C., Neslihan Alpay S., Klostergaard J. CD44: a validated target for improved delivery of cancer therapeutics. Expert Opin. Ther. Targets 2012, 16:635-650.
37. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer 2010, 46:1271-1277.
38. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 2003, 4:33-45.
39. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur. J. Cell. Biol. 2004, 83:317-325.
40. Sundaram M., Qi Y., Shriver Z., Liu D., Zhao G., Venkataraman G., Langer R., Sasisekharan R. Rational design of low-molecular weight heparins with improved in vivo activity. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:651-656.
41. Chung Y.-I., Tae G., Hong Yuk S. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 2006, 27:2621-2626.
42. Yip G.W., Smollich M., Götte M. Therapeutic value of glycosaminoglycans in cancer. Mol. Cancer Ther. 2006, 5:2139-2148.
43. Park J.H., Lee S., Kim J.-H., Park K., Kim K., Kwon I.C. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci. 2008, 33:113-137.
44. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9:615-627.
45. Yoo J.-W., Irvine D.J., Discher D.E., Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 2011, 10:521-535.
46. Lee S.J., Koo H., Lee D.-E., Min S., Lee S., Chen X., Choi Y., Leary J.F., Park K., Jeong S.Y., Kwon I.C., Kim K., Choi K. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 2011, 32:4021-4029.
47. Choi K.Y., Silvestre O.F., Huang X., Min K.H., Howard G.P., Hida N., Jin A.J., Carvajal N., Lee S.W., Hong J.-I., Chen X. Versatile RNA interference nanoplatform for systemic delivery of RNAs. ACS Nano 2014, 8:4559-4570.
48. Han H.S., Thambi T., Choi K.Y., Son S., Ko H., Lee M.C., Jo D.-G., Chae Y.S., Kang Y.M., Lee J.Y., Park J.H. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery. Biomacromolecules 2015, 16:447-456.
49. Shin J.M., Kim S.-H., Thambi T., You D.G., Jeon J., Lee J.O., Chung B.Y., Jo D.-G., Park J.H. A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis. Chem. Commun. 2014, 50:7632-7635.
50. Janes K.A., Calvo P., Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001, 47:83-97.
51. Schanté C.E., Zuber G., Herlin C., Vandamme T.F. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr. Polym. 2011, 85:469-489.
52. Kolishetti N., Dhar S., Valencia P.M., Lin L.Q., Karnik R., Lippard S.J., Langer R., Farokhzad O.C. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17939-17944.
53. Choi K.Y., Chung H., Min K.H., Yoon H.Y., Kim K., Park J.H., Kwon I.C., Jeong S.Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31:106-114.
54. Choi K.Y., Liu G., Lee S., Chen X. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 2012, 4:330-342.
55. Malam Y., Loizidou M., Seifalian A.M. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci. 2009, 30:592-599.
56. Chen Y., Zhu X., Zhang X., Liu B., Huang L. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 2010, 18:1650-1656.
57. Cho H.-J., Yoon H.Y., Koo H., Ko S.-H., Shim J.-S., Lee J.-H., Kim K., Chan Kwon I., Kim D.-D. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. Biomaterials 2011, 32:7181-7190.
58. Koo H., Min K.H., Lee S.C., Park J.H., Park K., Jeong S.Y., Choi K., Kwon I.C., Kim K. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. J. Control. Release 2013, 172:823-831.
59. Saravanakumar G., Min K.H., Min D.S., Kim A.Y., Lee C.-M., Cho Y.W., Lee S.C., Kim K., Jeong S.Y., Park K., Park J.H., Kwon I.C. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. J. Control. Release 2009, 140:210-217.
60. Jiang G., Park K., Kim J., Kim K.S., Hahn S.K. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol. Pharm. 2009, 6:727-737.
61. Saravanakumar G., Jo D.G., Park J.H. Polysaccharide-based nanoparticles: a versatile platform for drug delivery and biomedical imaging. Curr. Med. Chem. 2012, 19:3212-3229.
62. Thambi T., Park J.H. Recent advances in shell-sheddable nanoparticles for cancer therapy. J. Biomed. Nanotechnol. 2014, 10:1841-1862.
63. Mura S., Nicolas J., Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 2013, 12:991-1003.
64. Stuart M.A.C., Huck W.T.S., Genzer J., Muller M., Ober C., Stamm M., Sukhorukov G.B., Szleifer I., Tsukruk V.V., Urban M., Winnik F., Zauscher S., Luzinov I., Minko S. Emerging applications of stimuli-responsive polymer materials. Nat. Mater. 2010, 9:101-113.
65. Wei H., Zhuo R.-X., Zhang X.-Z. Design and development of polymeric micelles with cleavable links for intracellular drug delivery. Prog. Polym. Sci. 2013, 38:503-535.
66. Thambi T., You D.G., Han H.S., Deepagan V.G., Jeon S.M., Suh Y.D., Choi K.Y., Kim K., Kwon I.C., Yi G.-R., Lee J.Y., Lee D.S., Park J.H. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery. Adv. Healthcare Mater. 2014, 3:1829-1838.
67. Kozielski K.L., Tzeng S.Y., Hurtado De Mendoza B.A., Green J.J. Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells. ACS Nano 2014, 8:3232-3241.
68. Li K., Liu B. Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging. Chem. Soc. Rev. 2014, 43:6570-6597.
69. Wen Y., Oh J.K. Recent strategies to develop polysaccharide-based nanomaterials for biomedical applications. Macromol. Rapid Commun. 2014, 35:1819-1832.
70. Yuan W., Yuan J., Zhang F., Xie X. Syntheses, characterization, and in vitro degradation of ethyl cellulose-graft-poly(ε-caprolactone)-block-poly(l-lactide) copolymers by sequential ring-opening polymerization. Biomacromolecules 2007, 8:1101-1108.
71. Östmark E., Nyström D., Malmström E. Unimolecular nanocontainers prepared by ROP and subsequent ATRP from hydroxypropylcellulose. Macromolecules 2008, 41:4405-4415.
72. He Q., Wu W., Xiu K., Zhang Q., Xu F., Li J. Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles. Int. J. Pharm. 2013, 443:110-119.
73. Jing J., Alaimo D., De Vlieghere E., Jerome C., De Wever O., De Geest B.G., Auzely-Velty R. Tunable self-assembled nanogels composed of well-defined thermoresponsive hyaluronic acid-polymer conjugates. J. Mater. Chem. B. 2013, 1:3883-3887.
74. Yuan W., Zhang J., Zou H., Shen T., Ren J. Amphiphilic ethyl cellulose brush polymers with mono and dual side chains: facile synthesis, self-assembly, and tunable temperature-pH responsivities. Polymer 2012, 53:956-966.
75. Such G.K., Johnston A.P.R., Liang K., Caruso F. Synthesis and functionalization of nanoengineered materials using click chemistry. Prog. Polym. Sci. 2012, 37:985-1003.
76. Schatz C., Louguet S., Le Meins J.-F., Lecommandoux S. Polysaccharide-block-polypeptide copolymer vesicles: towards synthetic viral capsids. Angew. Chem. Int. Ed. 2009, 48:2572-2575.
77. Han H.S., Choi K.Y., Ko H., Jeon J., Saravanakumar G., Suh Y.D., Lee D.S., Park J.H. Bioreducible core-crosslinked hyaluronic acid micelle for targeted cancer therapy. J. Control. Release 2015, 200:158-166.
78. Upadhyay K.K., Bhatt A.N., Castro E., Mishra A.K., Chuttani K., Dwarakanath B.S., Schatz C., Le Meins J.-F., Misra A., Lecommandoux S. In vitro and In vivo Evaluation of docetaxel loaded biodegradable polymersomes. Macromol. Biosci. 2010, 10:503-512.
79. Upadhyay K.K., Bhatt A.N., Mishra A.K., Dwarakanath B.S., Jain S., Schatz C., Le Meins J.-F., Farooque A., Chandraiah G., Jain A.K., Misra A., Lecommandoux S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31:2882-2892.
80. Csaba N., Köping-Höggård M., Alonso M.J. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm. 2009, 382:205-214.
81. Giacalone G., Hillaireau H., Capiau P., Chacun H., Reynaud F., Fattal E. Stabilization and cellular delivery of chitosan-polyphosphate nanoparticles by incorporation of iron. J. Control. Release 2014, 194:211-219.
82. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., Alonso M.a.J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 2001, 73:255-267.
83. Lee J.Y., Lee S.H., Oh M.H., Kim J.S., Park T.G., Nam Y.S. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles. J. Control. Release 2012, 162:407-413.
84. Hamman J.H. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Mar. Drugs 2010, 8:1305-1322.
85. You J.-O., Peng C.-A. Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol. Symp. 2005, 219:147-153.
86. Zahoor A., Sharma S., Khuller G.K. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob. Agents 2005, 26:298-303.
87. Kim Y.-J., Chae S.Y., Jin C.-H., Sivasubramanian M., Son S., Choi K.Y., Jo D.-G., Kim K., Chan Kwon I., Lee K.C., Park J.H. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. Biomaterials 2010, 31:9057-9064.
88. Owen S.C., Chan D.P.Y., Shoichet M.S. Polymeric micelle stability. Nano Today 2012, 7:53-65.
89. Bae Y.H., Yin H. Stability issues of polymeric micelles. J. Control. Release 2008, 131:2-4.
90. Shrestha R., Elsabahy M., Florez-Malaver S., Samarajeewa S., Wooley K.L. Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities. Biomaterials 2012, 33:8557-8568.
91. Koo A.N., Lee H.J., Kim S.E., Chang J.H., Park C., Kim C., Park J.H., Lee S.C. Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery. Chem. Commun. 2008, 48:6570-6572.
92. Sasaki Y., Tsuchido Y., Sawada S.-i., Akiyoshi K. Construction of protein-crosslinked nanogels with vitamin B6 bearing polysaccharide. Polym. Chem. 2011, 2:1267-1270.
93. Li Y.-L., Zhu L., Liu Z., Cheng R., Meng F., Cui J.-H., Ji S.-J., Zhong Z. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew. Chem. Int. Ed. 2009, 48:9914-9918.
94. Han S.-Y., Han H.S., Lee S.C., Kang Y.M., Kim I.-S., Park J.H. Mineralized hyaluronic acid nanoparticles as a robust drug carrier. J. Mater. Chem. 2011, 21:7996-8001.
95. Perkin K.K., Turner J.L., Wooley K.L., Mann S. Fabrication of hybrid nanocapsules by calcium phosphate mineralization of shell cross-linked polymer micelles and nanocages. Nano Letters 2005, 5:1457-1461.
96. Lee H.J., Kim S.E., Kwon I.K., Park C., Kim C., Yang J., Lee S.C. Spatially mineralized self-assembled polymeric nanocarriers with enhanced robustness and controlled drug-releasing property. Chem. Commun. 2010, 46:377-379.
97. Zhang L., Gao S., Zhang F., Yang K., Ma Q., Zhu L. Activatable hyaluronic acid nanoparticle as a theranostic agent for optical/photoacoustic image-guided photothermal therapy. ACS Nano 2014, 8:12250-12258.
98. Choi K.Y., Yoon H.Y., Kim J.-H., Bae S.M., Park R.-W., Kang Y.M., Kim I.-S., Kwon I.C., Choi K., Jeong S.Y., Kim K., Park J.H. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 2011, 5:8591-8599.
99. Choi K.Y., Jeon E.J., Yoon H.Y., Lee B.S., Na J.H., Min K.H., Kim S.Y., Myung S.-J., Lee S., Chen X., Kwon I.C., Choi K., Jeong S.Y., Kim K., Park J.H. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials 2012, 33:6186-6193.
100. Yoon H.Y., Koo H., Choi K.Y., Chan Kwon I., Choi K., Park J.H., Kim K. Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery. Biomaterials 2013, 34:5273-5280.
101. Lee G.Y., Kim J.-H., Choi K.Y., Yoon H.Y., Kim K., Kwon I.C., Choi K., Lee B.-H., Park J.H., Kim I.-S. Hyaluronic acid nanoparticles for active targeting atherosclerosis. Biomaterials 2015, 53:341-348.
102. Cho H.-J., Yoon I.-S., Yoon H.Y., Koo H., Jin Y.-J., Ko S.-H., Shim J.-S., Kim K., Kwon I.C., Kim D.-D. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 2012, 33:1190-1200.
103. Park J.-H., Cho H.-J., Yoon H.Y., Yoon I.-S., Ko S.-H., Shim J.-S., Cho J.-H., Park J.H., Kim K., Kwon I.C., Kim D.-D. Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J. Control. Release 2014, 174:98-108.
104. Cho H.-J., Yoon H.Y., Koo H., Ko S.-H., Shim J.-S., Cho J.-H., Park J.H., Kim K., Kwon I.C., Kim D.-D. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. J. Control. Release 2012, 162:111-118.
105. Yoon H.Y., Kim H.R., Saravanakumar G., Heo R., Chae S.Y., Um W., Kim K., Kwon I.C., Lee J.Y., Lee D.S., Park J.C., Park J.H. Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting. J. Control. Release 2013, 172:653-661.
106. Park D., Cho Y., Goh S.-H., Choi Y. Hyaluronic acid-polypyrrole nanoparticles as pH-responsive theranostics. Chem. Commun. 2014, 50:15014-15017.
107. Jung H., Park K.M., Yang J.-A., Oh E.J., Lee D.-W., Park K., Ryu S.H., Hahn S.K., Kim K. Theranostic systems assembled in situ on demand by host-guest chemistry. Biomaterials 2011, 32:7687-7694.
108. Miki K., Inoue T., Kobayashi Y., Nakano K., Matsuoka H., Yamauchi F., Yano T., Ohe K. Near-infrared dye-conjugated amphiphilic hyaluronic acid derivatives as a dual contrast agent for in vivo optical and photoacoustic tumor imaging. Biomacromolecules 2015, 16:219-227.
109. El-Dakdouki M.H., Zhu D.C., El-Boubbou K., Kamat M., Chen J., Li W., Huang X. Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells. Biomacromolecules 2012, 13:1144-1151.
110. Šmejkalová D., Nešporová K., Huerta-Angeles G., Syrovátka J., Jirák D., Gálisová A., Velebný V. Selective in vitro anticancer effect of superparamagnetic iron oxide nanoparticles loaded in hyaluronan polymeric micelles. Biomacromolecules 2014, 15:4012-4020.
111. Zhang Y., Sun Y., Yang X., Hilborn J., Heerschap A., Ossipov D.A. Injectable in situ forming hybrid iron oxide-hyaluronic acid hydrogel for magnetic resonance imaging and drug delivery. Macromol. Biosci. 2014, 14:1249-1259.
112. Huang J., Zhang H., Yu Y., Chen Y., Wang D., Zhang G., Zhou G., Liu J., Sun Z., Sun D., Lu Y., Zhong Y. Biodegradable self-assembled nanoparticles of poly (d, l-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Biomaterials 2014, 35:550-566.
113. Kupal S.G., Cerroni B., Ghugare S.V., Chiessi E., Paradossi G. Biointerface properties of core-shell poly(vinyl alcohol)-hyaluronic acid microgels based on chemoselective chemistry. Biomacromolecules 2012, 13:3592-3601.
114. Miao W., Shim G., Kang C.M., Lee S., Choe Y.S., Choi H.-G., Oh Y.-K. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013, 34:9638-9647.
115. Nahain A.-A., Lee J.-E., Jeong J.H., Park S.Y. Photoresponsive fluorescent reduced graphene oxide by spiropyran conjugated hyaluronic acid for in vivo imaging and target delivery. Biomacromolecules 2013, 14:4082-4090.
116. 4 nanocrystals. Nanoscale Res. Lett. 2013, 8:149.
117. Park K.M., Yang J.-A., Jung H., Yeom J., Park J.S., Park K.-H., Hoffman A.S., Hahn S.K., Kim K. In situ supramolecular assembly and modular modification of hyaluronic acid hydrogels for 3D cellular engineering. ACS Nano 2012, 6:2960-2968.
118. Wang Z., Chen Z., Liu Z., Shi P., Dong K., Ju E., Ren J., Qu X. A multi-stimuli responsive gold nanocage-hyaluronic platform for targeted photothermal and chemotherapy. Biomaterials 2014, 35:9678-9688.
119. Lee Y.-H., Yoon H.Y., Shin J.M., Saravanakumar G., Noh K.H., Song K.-H., Jeon J.-H., Kim D.-W., Lee K.-M., Kim K., Kwon I.C., Park J.H., Kim T.W. A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo. J. Control. Release 2015, 199:98-105.
120. Bachar G., Cohen K., Hod R., Feinmesser R., Mizrachi A., Shpitzer T., Katz O., Peer D. Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers. Biomaterials 2011, 32:4840-4848.
121. Rivkin I., Cohen K., Koffler J., Melikhov D., Peer D., Margalit R. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 2010, 31:7106-7114.
122. Choi R., Yang J., Choi J., Lim E.-K., Kim E., Suh J.-S., Huh Y.-M., Haam S. Thiolated dextran-coated gold nanorods for photothermal ablation of inflammatory macrophages. Langmuir 2010, 26:17520-17527.
123. Jin R., Moreira Teixeira L.S., Dijkstra P.J., van Blitterswijk C.A., Karperien M., Feijen J. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials 2010, 31:3103-3113.
124. 4 nanoparticles as a theranostic platform for cellular imaging and drug delivery. Biomaterials 2012, 33:7895-7902.
125. Liu P., Yue C., Shi B., Gao G., Li M., Wang B., Ma Y., Cai L. Dextran based sensitive theranostic nanoparticles for near-infrared imaging and photothermal therapy in vitro. Chem. Commun. 2013, 49:6143-6145.
126. Kim S.-H., Kim J.-H., You D.G., Saravanakumar G., Yoon H.Y., Choi K.Y., Thambi T., Deepagan V.G., Jo D.-G., Park J.H. Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis. Chem. Commun. 2013, 49:10349-10351.
127. You D.G., Saravanakumar G., Son S., Han H.S., Heo R., Kim K., Kwon I.C., Lee J.Y., Park J.H. Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging. Carbohydr. Polym. 2014, 101:1225-1233.
128. Wang C., Ravi S., Garapati U.S., Das M., Howell M., Mallela J., Alwarappan S., Mohapatra S.S., Mohapatra S. Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents. J. Mater. Chem. B 2013, 1:4396-4405.
129. Stephen Z.R., Kievit F.M., Veiseh O., Chiarelli P.A., Fang C., Wang K., Hatzinger S.J., Ellenbogen R.G., Silber J.R., Zhang M. Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors. ACS Nano 2014, 8:10383-10395.
130. Oh I.-h., Min H.S., Li L., Tran T.H., Lee Y.-k., Kwon I.C., Choi K., Kim K., Huh K.M. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials 2013, 34:6454-6463.
131. Lim C.-K., Shin J., Kwon I.C., Jeong S.Y., Kim S. Iodinated photosensitizing chitosan: self-assembly into tumor-homing nanoparticles with enhanced singlet oxygen generation. Bioconjugate Chem. 2012, 23:1022-1028.
132. Wei W., Lv P.-P., Chen X.-M., Yue Z.-G., Fu Q., Liu S.-Y., Yue H., Ma G.-H. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression. Biomaterials 2013, 34:3912-3923.
133. Yoon H.Y., Son S., Lee S.J., You D.G., Yhee J.Y., Park J.H., Swierczewska M., Lee S., Kwon I.C., Kim S.H., Kim K., Pomper M.G. Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA. Sci. Rep. 2014, 4:6878.
134. Yhee J.Y., Song S., Lee S.J., Park S.-G., Kim K.-S., Kim M.G., Son S., Koo H., Kwon I.C., Jeong J.H., Jeong S.Y., Kim S.H., Kim K. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. J. Control. Release 2015, 198:1-9.
135. Lee S.J., Huh M.S., Lee S.Y., Min S., Lee S., Koo H., Chu J.-U., Lee K.E., Jeon H., Choi Y., Choi K., Byun Y., Jeong S.Y., Park K., Kim K., Kwon I.C. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment. Angew. Chem. Int. Ed. Engl. 2012, 51:7203-7207.
136. Shen J., Kim H.-C., Su H., Wang F., Wolfram J., Kirui D., Mai J., Mu C., Ji L.-N., Mao Z.-W., Shen H. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics 2014, 4:487-497.
137. Heo D.N., Ko W.-K., Moon H.-J., Kim H.-J., Lee S.J., Lee J.B., Bae M.S., Yi J.-K., Hwang Y.-S., Bang J.B., Kim E.-C., Do S.H., Kwon I.K. Inhibition of osteoclast differentiation by gold nanoparticles functionalized with cyclodextrin curcumin complexes. ACS Nano 2014, 8:12049-12062.
138. Namgung R., Mi Lee Y., Kim J., Jang Y., Lee B.-H., Kim I.-S., Sokkar P., Rhee Y.M., Hoffman A.S., Kim W.J. Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy. Nat. Commun. 2014, 5:3702.
139. Heo D.N., Yang D.H., Moon H.-J., Lee J.B., Bae M.S., Lee S.C., Lee W.J., Sun I.-C., Kwon I.K. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012, 33:856-866.
140. Sivasubramanian M., Thambi T., Deepagan V.G., Saravanakumar G., Ko H., Kang Y.M., Park J.H. Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin. J. Nanosci. Nanotechnol. 2013, 13:7271-7278.
141. Wang Y., Chen H., Liu Y., Wu J., Zhou P., Wang Y., Li R., Yang X., Zhang N. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma. Biomaterials 2013, 34:7181-7190.
142. Scomparin A., Salmaso S., Eldar-Boock A., Ben-Shushan D., Ferber S., Tiram G., Shmeeda H., Landa-Rouben N., Leor J., Caliceti P., Gabizon A., Satchi-Fainaro R. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index. J. Control. Release 2015, 208:106-120.
143. Yim H., Park S.-j., Bae Y.H., Na K. Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours. Biomaterials 2013, 34:7674-7682.
144. She W., Li N., Luo K., Guo C., Wang G., Geng Y., Gu Z. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 2013, 34:2252-2264.
145. Yue C., Liu P., Zheng M., Zhao P., Wang Y., Ma Y., Cai L. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials 2013, 34:6853-6861.
146. Han H.S., Lee J., Kim H.R., Chae S.Y., Kim M., Saravanakumar G., Yoon H.Y., You D.G., Ko H., Kim K., Kwon I.C., Park J.C., Park J.H. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo. J. Control. Release 2013, 168:105-114.
147. Lokeshwar V.B., Lokeshwar B.L., Pham H.T., Block N.L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 1996, 56:651-657.
148. Tomihata K., Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 1997, 18:567-575.
149. Lee K.Y., Ha W.S., Park W.H. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 1995, 16:1211-1216.
150. Kean T., Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev. 2010, 62:3-11.
151. Guibal E., Vincent T., Navarro R. Metal ion biosorption on chitosan for the synthesis of advanced materials. J. Mater. Sci. 2014, 49:5505-5518.
152. Na J.H., Koo H., Lee S., Min K.H., Park K., Yoo H., Lee S.H., Park J.H., Kwon I.C., Jeong S.Y., Kim K. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials 2011, 32:5252-5261.
153. Bhattarai N., Ramay H.R., Gunn J., Matsen F.A., Zhang M. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Control. Release 2005, 103:609-624.
154. Germershaus O., Mao S.R., Sitterberg J., Bakowsky U., Kissel T. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. J. Control. Release 2008, 125:145-154.
155. Kumar M.N.V.R., Muzzarelli R.A.A., Muzzarelli C., Sashiwa H., Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 2004, 104:6017-6084.
156. Tan S.C., Khor E., Tan T.K., Wong S.M. The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination. Talanta 1998, 45:713-719.
157. Svenson S., Wolfgang M., Hwang J., Ryan J., Eliasof S. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101. J. Control. Release 2011, 153:49-55.
158. Zuckerman J.E., Gritli I., Tolcher A., Heidel J.D., Lim D., Morgan R., Chmielowski B., Ribas A., Davis M.E., Yen Y. Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:11449-11454.